Nomenclature	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=450	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=451	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=452	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=453	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=454
HGNC, UniProt	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4579, http://www.uniprot.org/uniprot/P39086	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4580, http://www.uniprot.org/uniprot/Q13002	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4581, http://www.uniprot.org/uniprot/Q13003	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4582, http://www.uniprot.org/uniprot/Q16099	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:4583, http://www.uniprot.org/uniprot/Q16478
Agonists	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4185 [http://www.ncbi.nlm.nih.gov/pubmed/11160654?dopt=AbstractPlus] – Rat, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4317 [http://www.ncbi.nlm.nih.gov/pubmed/10821708?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4231 [http://www.ncbi.nlm.nih.gov/pubmed/9849663?dopt=AbstractPlus], (http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4069, (http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4071, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4112, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4140, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4181	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4185 [http://www.ncbi.nlm.nih.gov/pubmed/11160654?dopt=AbstractPlus] – Rat, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4181 [http://www.ncbi.nlm.nih.gov/pubmed/8809152?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4317 [http://www.ncbi.nlm.nih.gov/pubmed/8996224?dopt=AbstractPlus] – Rat, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4231 [http://www.ncbi.nlm.nih.gov/pubmed/8809152?dopt=AbstractPlus, http://www.ncbi.nlm.nih.gov/pubmed/9849663?dopt=AbstractPlus]	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4317 [http://www.ncbi.nlm.nih.gov/pubmed/18578478?dopt=AbstractPlus] – Rat, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4231 (low potency) [http://www.ncbi.nlm.nih.gov/pubmed/18578478?dopt=AbstractPlus] – Rat, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4185	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4317, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4181, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4185, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4231	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4317, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4181, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4185, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4231
Selective agonists	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4246 [http://www.ncbi.nlm.nih.gov/pubmed/9849663?dopt=AbstractPlus]	–	–	–	–
Selective antagonists	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4102, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4123, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4247, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4250, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4258, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4274 (non‐competitive), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4333, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4334	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4102	–	–	–
Allosteric modulators	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4162 (Positive)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4162 (Positive)	–	–	–
Labelled ligands	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4092 (Antagonist) (pK d 7.7) [http://www.ncbi.nlm.nih.gov/pubmed/20837679?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4075 (Agonist), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4085 (Agonist)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4085 (Agonist) [http://www.ncbi.nlm.nih.gov/pubmed/8996224?dopt=AbstractPlus] – Rat, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4075 (Agonist)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4092 (Antagonist) (pK d 6.3) [http://www.ncbi.nlm.nih.gov/pubmed/20837679?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4075 (Agonist), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4085 (Agonist)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4075 (Agonist), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4085 (Agonist)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4075 (Agonist), http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4085 (Agonist)
Comments	–	Intracellular polyamines are subtype selective channel blockers (GluK3 ≫ GluK2)	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4181 and http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4162 are inactive at the GluK3 subunit. Intracellular polyamines are subtype selective channel blockers (GluK3 ≫ GluK2)	–	–